COO & QA Manager Houman Pourhassan, PhD, has a background in immuno-oncology and drug development. Houman’s area of expertise includes multicolor flow cytometry, animal cancer models, and mammalian microbiology. In addition to high-impact scientific publications in the field of immunomodulation and nanoparticle anticancer drugs, he is experienced in industry standard GMP and PRINCE2® project management.
Associate Cecilie is BSc Eng from the Danish Technical University and currently attending the MSc programme in Biotechnology engineering.
Cecilie has broad experience in both scientific, sales and administrative areas.
Founder and business advisor, Søren Nyboe Jakobsen, previously worked for Immudex with responsibilities in areas of technology innovation, technology development, IP securing, new products development, business development, marketing, online marketing and branding. He has major experience with the production and use of MHC Dextramers. Søren is the inventor/co-inventor of several issued patents on molecular-display techniques, molecular selection and high-throughput screening techniques including high-throughput epitope discovery techniques.
Research Scientist Philip V. Hansen, has a background as MSc of biotechnology from the University of Copenhagen, with specialization in cell physiology, genetic editing and process optimization. He has been involved with life science business and has worked with investment strategies, business evaluation and project management.